Neuronetics, Inc. – NASDAQ:STIM
Neuronetics stock price today
$3.4
+1.92
+129.73%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 14 hours
Neuronetics stock price monthly change
-20.86%
month
Neuronetics stock price quarterly change
-20.86%
quarter
Neuronetics stock price yearly change
-45.59%
year
Neuronetics key metrics
Market Cap | 44.76M |
Enterprise value | 36.60M |
P/E | -1.98 |
EV/Sales | 0.56 |
EV/EBITDA | -1.17 |
Price/Sales | 1.03 |
Price/Book | 1.17 |
PEG ratio | 0.15 |
EPS | -0.96 |
Revenue | 73.22M |
EBITDA | -21.2M |
Income | -27.54M |
Revenue Q/Q | 12.07% |
Revenue Y/Y | 10.00% |
Profit margin | -56.99% |
Oper. margin | -53.85% |
Gross margin | 76.26% |
EBIT margin | -53.85% |
EBITDA margin | -28.95% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNeuronetics stock price history
Neuronetics stock forecast
Neuronetics financial statements
| Jun 2023 | 17.61M | -4.90M | -27.83% |
|---|---|---|---|
| Sep 2023 | 17.88M | -9.39M | -52.51% |
| Dec 2023 | 20.31M | -5.37M | -26.47% |
| Mar 2024 | 17.41M | -7.87M | -45.2% |
| Mar 2024 | 17.41M | -7.87M | -45.2% |
|---|---|---|---|
| Sep 2025 | 22.38M | -4.55M | -20.33% |
| Oct 2025 | 22.15M | -4.92M | -22.21% |
| Dec 2025 | 24.64M | -3.55M | -14.42% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 100392000 | 54.91M | 54.7% |
|---|---|---|---|
| Sep 2023 | 92988000 | 55.04M | 59.2% |
| Dec 2023 | 115831000 | 81.64M | 70.48% |
| Mar 2024 | 103811000 | 76.15M | 73.36% |
| Jun 2023 | -15.03M | 5.55M | -62K |
|---|---|---|---|
| Sep 2023 | -10.12M | 66K | 0 |
| Dec 2023 | 2.13M | -563K | 22.26M |
| Mar 2024 | -12.01M | 68K | 0 |
Neuronetics alternative data
| Aug 2023 | 200 |
|---|---|
| Sep 2023 | 209 |
| Oct 2023 | 209 |
| Nov 2023 | 209 |
| Dec 2023 | 211 |
| Jan 2024 | 211 |
| Feb 2024 | 211 |
| Mar 2024 | 203 |
| Apr 2024 | 203 |
| May 2024 | 203 |
| Jun 2024 | 202 |
| Jul 2024 | 202 |
Neuronetics other data
77.39%
+1.40%
of STIM is owned by hedge funds
19.71M
-267.32K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2023 | 0 | 34991 |
| Jan 2024 | 0 | 19529 |
| Feb 2024 | 0 | 181040 |
| Jun 2024 | 50000 | 0 |
| Jul 2024 | 0 | 47924 |
| Aug 2024 | 184171 | 0 |
| Sep 2024 | 125000 | 0 |
| Oct 2024 | 0 | 2909 |
| Patent |
|---|
Application MAGNETIC STIMULATION COILS AND FERROMAGNETIC COMPONENTS FOR REDUCED SURFACE STIMULATION AND IMPROVED TREATMENT DEPTH Filling date: 28 Feb 2022 Issue date: 9 Jun 2022 |
Application Filling date: 14 Oct 2021 Issue date: 3 Feb 2022 |
Application Filling date: 16 Apr 2021 Issue date: 29 Jul 2021 |
Application Filling date: 22 Mar 2021 Issue date: 8 Jul 2021 |
Grant Utility: Magnetic stimulation coils and ferromagnetic components for treatment and diagnostic procedures Filling date: 20 Feb 2018 Issue date: 11 May 2021 |
Grant Filling date: 10 Dec 2018 Issue date: 20 Apr 2021 |
Application Filling date: 9 Apr 2020 Issue date: 6 Aug 2020 |
Application Filling date: 10 Mar 2020 Issue date: 2 Jul 2020 |
Grant Filling date: 8 Mar 2019 Issue date: 28 Apr 2020 |
Grant Utility: Magnetic core for medical procedures Filling date: 21 Feb 2018 Issue date: 14 Apr 2020 |
| Quarter | Transcript |
|---|---|
| Q1 2024 7 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 5 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 8 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. Keith J. Sullivan (1958) Pres, Chief Executive Officer & Director | $832,670 |
Mr. Stephen J. Furlong M.S. (1965) Senior Vice President, Chief Financial Officer & Treasurer | $701,670 |
Mr. W. Andrew Macan (1973) Senior Vice President, Gen. Counsel, Chief Compliance Officer, Sec. & Member of Office of the Pres | $692,610 |
-
What's the price of Neuronetics stock today?
One share of Neuronetics stock can currently be purchased for approximately $3.4.
-
When is Neuronetics's next earnings date?
Unfortunately, Neuronetics's (STIM) next earnings date is currently unknown.
-
Does Neuronetics pay dividends?
No, Neuronetics does not pay dividends.
-
How much money does Neuronetics make?
Neuronetics has a market capitalization of 44.76M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 9.42% to 71.35M US dollars.
-
What is Neuronetics's stock symbol?
Neuronetics, Inc. is traded on the NASDAQ under the ticker symbol "STIM".
-
What is Neuronetics's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Neuronetics?
Shares of Neuronetics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Neuronetics's key executives?
Neuronetics's management team includes the following people:
- Mr. Keith J. Sullivan Pres, Chief Executive Officer & Director(age: 67, pay: $832,670)
- Mr. Stephen J. Furlong M.S. Senior Vice President, Chief Financial Officer & Treasurer(age: 60, pay: $701,670)
- Mr. W. Andrew Macan Senior Vice President, Gen. Counsel, Chief Compliance Officer, Sec. & Member of Office of the Pres(age: 52, pay: $692,610)
-
How many employees does Neuronetics have?
As Jul 2024, Neuronetics employs 202 workers, which is 0% less then previous quarter.
-
When Neuronetics went public?
Neuronetics, Inc. is publicly traded company for more then 7 years since IPO on 28 Jun 2018.
-
What is Neuronetics's official website?
The official website for Neuronetics is neurostar.com.
-
Where are Neuronetics's headquarters?
Neuronetics is headquartered at 3222 Phoenixville Pike, Malvern, PA.
-
How can i contact Neuronetics?
Neuronetics's mailing address is 3222 Phoenixville Pike, Malvern, PA and company can be reached via phone at +61 6404202.
Neuronetics company profile:
Neuronetics, Inc.
neurostar.comExchange:
NASDAQ
Full time employees:
203
Industry:
Medical - Diagnostics & Research
Sector:
Healthcare
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
3222 Phoenixville Pike
Malvern, PA 19355
Malvern, PA 19355
CIK: 0001227636
ISIN: US64131A1051
CUSIP: 64131A105
